米国企業
CATALYST PHARMACEUTICALS, INC.

CATALYST PHARMACEUTICALS, INC.CPRX

時価総額

$19.4億

PER

27.2倍

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	6	1	2	9	28	14	57	17	90	130	171	298	138
Short-term investments	-	8	17	26	26	27	27	37	5	10	20	-	-
Accounts receivable, net	-	-	-	-	-	-	-	-	11	6	7	10	54
Accounts receivable, net	-	-	-	-	-	-	-	-	11	6	7	10	54
Inventory	-	-	-	-	-	-	-	56,012	2	5	8	7	16
Inventory	-	-	-	-	-	-	-	56,012	2	5	8	7	16
Prepaid expenses and other current assets	199,116	1	2	5	2	1	1	2	4	8	4	5	13
Prepaid expenses and other current assets	199,116	1	2	5	2	1	1	2	4	8	4	5	13
Total current assets	6	17	25	44	60	41	85	55	111	159	210	321	219
Total current assets	6	17	25	44	60	41	85	55	111	159	210	321	219
Operating lease right-of-use asset	-	-	-	-	-	-	-	-	793,252	-	3	3	3
Operating lease right-of-use asset	-	-	-	-	-	-	-	-	793,252	-	3	3	3
Property and equipment, net	12,186	53,679	40,628	71,377	191,549	244,204	191,385	245,425	210,467	129,800	1	1	1
Property and equipment, net	12,186	53,679	40,628	71,377	191,549	244,204	191,385	245,425	210,467	129,800	1	1	1
Finite-Lived Intangible Assets, Net	-	-	-	-	-	-	-	-	-	-	-	32	194
Finite-Lived Intangible Assets, Net	-	-	-	-	-	-	-	-	-	-	-	32	194
Deferred tax assets, net	-	-	-	-	-	-	-	-	-	33	24	19	37
Deferred tax assets, net	-	-	-	-	-	-	-	-	-	33	24	19	37
Investment in equity securities	-	-	-	-	-	-	-	-	-	-	-	-	16
Deposits	8,888	8,888	8,888	8,888	8,888	8,888	8,888	8,888	8,888	8,888	0	0	-
Total assets	6	17	25	44	60	42	85	60	112	192	238	376	470
Total assets	6	17	25	44	60	42	85	60	112	192	238	376	470
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	647,532	-	4	4	3
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	647,532	-	4	4	3
Other non-current liabilities	2	498,587	-	-	-	-	-	-	-	-	-	14	3
Other non-current liabilities	2	498,587	-	-	-	-	-	-	-	-	-	14	3
Total liabilities	2	2	4	9	5	2	4	10	25	23	31	75	82
Total liabilities	2	2	4	9	5	2	4	10	25	23	31	75	82
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Accumulated other comprehensive income (Note 4)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Accumulated other comprehensive income (loss)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Accumulated other comprehensive income (Note 4)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Accumulated other comprehensive income (loss)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total liabilities and stockholders' equity	6	17	25	44	60	42	85	60	112	192	238	376	470
Total liabilities and stockholders' equity	6	17	25	44	60	42	85	60	112	192	238	376	470
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Accrued Liabilities, Current	569,867	281,002	1	4	2	1	2	7	20	19	24	54	61
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	647,532	-	4	4	3
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	647,532	-	4	4	3
Other non-current liabilities	2	498,587	-	-	-	-	-	-	-	-	-	14	3
Other non-current liabilities	2	498,587	-	-	-	-	-	-	-	-	-	14	3
Total liabilities	2	2	4	9	5	2	4	10	25	23	31	75	82
Total liabilities	2	2	4	9	5	2	4	10	25	23	31	75	82
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Accumulated other comprehensive income (Note 4)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Accumulated other comprehensive income (loss)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Common Stock, Value, Issued	24,701	41,421	54,133	69,119	82,851	82,972	102,549	102,739	103,397	103,782	0	0	0
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Additional paid-in capital	42	57	76	105	145	147	207	211	216	223	233	250	266
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121
Accumulated other comprehensive income (Note 4)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Accumulated other comprehensive income (loss)	-	-	-	-	-	-	-	-20,248	9,505	31,332	-0	0	0
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388
Total liabilities and stockholders' equity	6	17	25	44	60	42	85	60	112	192	238	376	470
Total liabilities and stockholders' equity	6	17	25	44	60	42	85	60	112	192	238	376	470